Amniotics AB (OSTO:AMNI) Net Interest Income : kr-1.19 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Amniotics AB's net interest income for the three months ended in Dec. 2023 was kr-0.36 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2023 was kr-1.19 Mil.

Amniotics AB Net Interest Income Historical Data

The historical data trend for Amniotics AB's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Net Interest Income Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Interest Income

-1.35

-1.80

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Net Interest Income	Get a 7-Day Free Trial										-0.64	-0.64	-0.19	-0.64	-0.36

Amniotics AB Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.19 Mil.

Amniotics AB Net Interest Income Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Net Interest Income

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.